Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

Por Rubinstein, Ethan, Stryjewski, Martin E, Barriere, Steven L
Publicado em 2014

Reply to Tarchini

Por Rubinstein, Ethan, Corey, G. Ralph, Stryjewski, Martin E., Barriere, Steven L.
Publicado em 2011

Potential Role for Telavancin in Bacteremic Infections Due to Gram-Positive Pathogens: Focus on Staphylococcus aureus

Por Corey, G. Ralph, Rubinstein, Ethan, Stryjewski, Martin E., Bassetti, Matteo, Barriere, Steven L.
Publicado no Clin Infect Dis (2015)

Telavancin for Acute Bacterial Skin and Skin Structure Infections, a Post Hoc Analysis of the Phase 3 ATLAS Trials in Light of the 2013 FDA Guidance

Por Pushkin, Richard, Barriere, Steven L., Wang, Whedy, Corey, G. Ralph, Stryjewski, Martin E.
Publicado no Antimicrob Agents Chemother (2015)

Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3...

Por Barriere, Steven L, Stryjewski, Martin E, Corey, G Ralph, Genter, Fredric C, Rubinstein, Ethan
Publicado em 2014

Assessment of Minimum Inhibitory Concentrations of Telavancin by Revised Broth Microdilution Method in Phase 3 Hospital-Acquired Pneumonia/Ventilator-Associated Pneumonia Clinical...

Por Smart, Jennifer I., Corey, Gordon Ralph, Stryjewski, Martin E., Wang, Whedy, Barriere, Steven L.
Publicado no Infect Dis Ther (2016)

Sepsis, Multiple Organ Failure, and Death Due to Pandoraea pnomenusa Infection after Lung Transplantation

Por Stryjewski, Martin E., LiPuma, John J., Messier, Jr., Robert H., Reller, L. Barth, Alexander, Barbara D.
Publicado em 2003

TD-1792 versus Vancomycin for Treatment of Complicated Skin and Skin Structure Infections

Por Stryjewski, Martin E., Potgieter, Peter D., Li, Yu-Ping, Barriere, Steven L., Churukian, Allan, Kingsley, Jeff, Corey, G. Ralph
Publicado em 2012

A Phase 2 study of the novel fluoroquinolone JNJ-Q2 in community-acquired bacterial pneumonia

Por Covington, Paul S., Davenport, J. Michael, Andrae, David A., Stryjewski, Martin E., Turner, Lisa L., McIntyre, Gail, Almenoff, June
Publicado em 2013

Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival

Por Corey, G. Ralph, Kollef, Marin H., Shorr, Andrew F., Rubinstein, Ethan, Stryjewski, Martin E., Hopkins, Alan, Barriere, Steven L.
Publicado em 2014

Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival

Por Corey, G. Ralph, Kollef, Marin H., Shorr, Andrew F., Rubinstein, Ethan, Stryjewski, Martin E., Hopkins, Alan, Barriere, Steven L.
Publicado em 2014

Determination of an Inoculum Effect with Various Cephalosporins among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus

Por Nannini, Esteban C., Stryjewski, Martin E., Singh, Kavindra V., Rude, Tom H., Corey, G. Ralph, Fowler, Vance G., Murray, Barbara E.
Publicado em 2010

Osteoblasts Express the Inflammatory Cytokine Interleukin-6 in a Murine Model of Staphylococcus aureus Osteomyelitis and Infected Human Bone Tissue

Por Marriott, Ian, Gray, David L., Tranguch, Susanne L., Fowler, Vance G., Stryjewski, Martin, Scott Levin, L., Hudson, Michael C., Bost, Kenneth L.
Publicado em 2004

Inoculum Effect with Cefazolin among Clinical Isolates of Methicillin-Susceptible Staphylococcus aureus: Frequency and Possible Cause of Cefazolin Treatment Failure

Por Nannini, Esteban C., Stryjewski, Martin E., Singh, Kavindra V., Bourgogne, Agathe, Rude, Tom H., Corey, G. Ralph, Fowler, Vance G., Murray, Barbara E.
Publicado em 2009

Gram-Negative Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group

Por Doi, Yohei, Bonomo, Robert A., Hooper, David C., Kaye, Keith S., Johnson, James R., Clancy, Cornelius J., Thaden, Joshua T., Stryjewski, Martin E., van Duin, David
Publicado no Clin Infect Dis (2017)

Presence of Genes Encoding the Panton-Valentine Leukocidin Exotoxin Is Not the Primary Determinant of Outcome in Patients with Complicated Skin and Skin Structure Infections Due to...

Por Bae, In-Gyu, Tonthat, Giang T., Stryjewski, Martin E., Rude, Thomas H., Reilly, Lindsay F., Barriere, Steven L., Genter, Fredric C., Corey, G. Ralph, Fowler, Vance G.
Publicado em 2009

Genotypic Characteristics of Staphylococcus aureus Isolates from a Multinational Trial of Complicated Skin and Skin Structure Infections

Por Campbell, Steven J., Deshmukh, Hitesh S., Nelson, Charlotte L., Bae, In-Gyu, Stryjewski, Martin E., Federspiel, Jerome J., Tonthat, Giang T., Rude, Thomas H., Barriere, Steven L., Corey, Ralph, Fowler, Vance G.
Publicado em 2008

A randomized Phase 2 trial of telavancin versus standard therapy in patients with uncomplicated Staphylococcus aureus bacteremia: the ASSURE study

Por Stryjewski, Martin E, Lentnek, Arnold, O’Riordan, William, Pullman, John, Tambyah, Paul Anantharajah, Miró, Jose M, Fowler Jr, Vance G, Barriere, Steven L, Kitt, Michael M, Corey, G Ralph
Publicado em 2014

Prospective Multicenter Study of Community-Associated Skin and Skin Structure Infections due to Methicillin-Resistant Staphylococcus aureus in Buenos Aires, Argentina

Por López Furst, María José, de Vedia, Lautaro, Fernández, Silvina, Gardella, Noella, Ganaha, María Cristina, Prieto, Sergio, Carbone, Edith, Lista, Nicolás, Rotryng, Flavio, Morera, Graciana I., Mollerach, Marta, Stryjewski, Martín E.
Publicado em 2013

Outcomes of Staphylococcus aureus Infection in Hemodialysis-Dependent Patients

Por Li, Yanhong, Friedman, Joëlle Y., O'Neal, Betsy F., Hohenboken, Matthew J., Griffiths, Robert I., Stryjewski, Martin E., Middleton, John P., Schulman, Kevin A., Inrig, Jula K., Fowler, Vance G., Reed, Shelby D.
Publicado em 2009